CClinicalTrials.gg
Not yet recruitingNCT07240545Updated Nov 21, 2025

Xylitol Gum for Promoting Smoking Cessation

An interventional study of Brief smoking cessation advice and Warning leaflet in Smoking Cessation and Health Promotion, sponsored by The University of Hong Kong. Not yet recruiting at 1 site in Hong Kong. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-21.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Feb 2026, 7 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
134
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn if 4-week xylitol gum intervention works to promote smoking cessation in daily smokers. It will also learn about the feasibility and acceptability of using xylitol gum. The main questions it aims to answer are:

(1)Does xylitol gum help to reduce cigarette consumption and promote smoking cessation?

Researchers will compare 4-week xylitol gum intervention to the brief advice to see if xylitol gum works to promote smoking cessation.

Participants in the intervention group will receive a 3-month behavioral intervention comprising a 4-week xylitol gum aligned with 12 weeks of instant reminder message support.

Read the detailed description

This study aims to evaluate the feasibility, acceptability, and preliminary effectiveness of a proactive smoking cessation intervention using xylitol chewing gum. Eligible participants will be Hong Kong residents aged ≥18 years who (1) have smoked at least one cigarette per day in the past 3 months; (2) can communicate in Cantonese (including reading Chinese); (3) express an intention to quit or reduce smoking; (4) are able to use instant messaging tools (e.g., WhatsApp); and (5) regularly chew gum or are willing to use chewing gum for smoking reduction.

A total of 134 participants will be recruited from community settings, including public housing estates across Hong Kong's 18 districts, community and university smoking hotspots, referrals from other smoking cessation programmes, and social media promotions (Facebook and Instagram). The study will adopt a hybrid type I effectiveness-implementation design. Participants will be followed up at 1, 3, and 6 months post-enrolment via telephone, following CONSORT guidelines, to assess cigarette reduction and cessation outcomes.

All participants will receive brief smoking cessation advice at baseline using the AWARD model (Ask/Assess, Warn, Advise, Refer, and Do-it-again), accompanied by a health warning leaflet and a smoking cessation information booklet.

Interventions are as follows:

Chewing gum group (intervention): Participants will receive 4 packs of xylitol gum at baseline and up to 24 packs throughout the 12-week intervention. Approximately 24 reminder messages (two per week), developed based on the Love and Care Approach framework, will be delivered via instant messaging to reinforce motivation and adherence.

Unassisted quitting group (control): Participants will receive brief advice only at baseline.

To explore user experience and acceptability, semi-structured qualitative interviews will be conducted with 20 intervention-group participants to understand their perceptions and experiences with xylitol gum use.

The primary outcome is biochemically validated smoking abstinence at 6 months, defined as exhaled carbon monoxide \<4 ppm and salivary cotinine \<30 ng/mL.

02

Conditions studied

  • Smoking Cessation
  • Health Promotion

Browse trials for

Keywords

  • Xylitol gum
  • Smoking cessation
  • Hybrid type 1 effectiveness-implementation design
03

In context

Smoking Cessation

304 studies on the registry are indexed under Smoking Cessation; 139 are open to participants now.

This study's planned enrollment of 134 is below the median of 154 across 285 interventional studies indexed under Smoking Cessation.

Browse Smoking Cessation studies →

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Residents of Hong Kong aged 18 or above who smoke at least 1 cigarette per day over the past 3 months
  • Have the habit of chewing gum or are willing to use chewing gum
  • Can communicate in Cantonese (including reading Chinese)
  • Express an intention to quit or reduce smoking
  • Capable of using instant messaging tools (e.g., WhatsApp, WeChat) for communication

Exclusion criteria

Exclusion Criteria:

  • Have communication barriers (either physical or cognitive)
  • Currently participating in other smoking cessation programs or services
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
134 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Participants assigned to the intervention group will receive a 3-month behavioral intervention comprising a 4-week xylitol gum aligned with 12 weeks of instant reminder message support.

    Behavioral: Brief smoking cessation advice · Behavioral: Warning leaflet · Behavioral: Self-help smoking cessation booklet · Behavioral: 4-week xylitol gum intervention · Behavioral: Instructional leaflet · Behavioral: 12-week instant message support

  • Active comparator
    Control group

    Participants in the control group will receive brief SC advice and a SC information booklet at baseline, which had been routinely used in our previous trials.

    Behavioral: Brief smoking cessation advice · Behavioral: Warning leaflet · Behavioral: Self-help smoking cessation booklet

Interventions

  • BehavioralBrief smoking cessation advice

    Brief smoking cessation advice guided by the validated AWARD model (Assess, Warning, Advice, Refer, and Do-it-again).

  • BehavioralWarning leaflet

    The warning leaflet contains pictorial depictions of the adverse health effects of smoking.

  • BehavioralSelf-help smoking cessation booklet

    The self-help smoking cessation booklet includes commonly used smoking cessation strategies.

  • Behavioral4-week xylitol gum intervention

    Participants in the intervention group will receive 4 packs of xylitol gum (approximately US $2 per pack) at baseline and will be encouraged to use it when they experience cravings.

  • BehavioralInstructional leaflet

    The instructional leaflet includes the potential benefits of xylitol gum for smoking cessation, recommended timing and dosage for use, and appropriate disposal of used gum.

  • Behavioral12-week instant message support

    Approximately 24 reminder messages (two per week), developed based on the Love and Care Approach framework, will be delivered over the 12-week period to reinforce motivation and adherence.

06

What researchers measure

Primary outcomes

  1. Biochemically validated smoking abstinence

    Verified by exhaled carbon monoxide \<4 ppm and salivary cotinine \<30 ng/ml

    Time frame: 6-month follow-up

Secondary outcomes

  1. Biochemically validated smoking abstinence

    Verified by exhaled carbon monoxide \<4 ppm and salivary cotinine \<30 ng/ml

    Time frame: 3-month follow-up

  2. Self-report 7-day point-prevalence abstinence

    By asking a question, "Have you smoked (even a puff) during the past 7 days?"

    Time frame: 1-, 3-, and 6-months follow-ups

  3. Smoking reduction

    Defined by a reduction of≥50% in daily cigarette consumption compared with baseline.

    Time frame: 1-, 3-, and 6-months follow-ups

  4. Quit attempt

    By asking a question, "Have you attempted to stop smoking completely for at least 24 hours in the past 7 days?"

    Time frame: 1-, 3-, and 6-months follow-ups

Other outcomes

  1. Number of pieces of xylitol gum used

    Total daily count used during the intervention period

    Time frame: 1- and 3-month follow-ups

  2. Frequency of using xylitol gum

    Average number of chewing episodes per day.

    Time frame: 1- and 3-month follow-ups

  3. Duration of use

    Average time spent chewing each piece.

    Time frame: 1- and 3-month follow-ups

07

Study locations

1 site
  • School of Nursing, The University of Hong Kong
    Hong Kong, Hong Kong
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07240545
Lead sponsor
The University of Hong Kong
Responsible party
Prof. Wang Man-Ping (Professor, The University of Hong Kong) — Principal investigator
First posted
Nov 21, 2025
Start date
Nov 24, 2025 (estimated)
Primary completion
Feb 28, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Nov 21, 2025

Study contacts

Mengyao Li, Mphil
Contact
lmy0814@connect.hku.hk
+852 6851 8462
Man Ping Wang, PhD
Contact
mpwang@hku.hk
+852 3917 6636
Man Ping Wang, PhD
principal investigator · The University of Hong Kong

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion